Cite
MLA Citation
Silvia Lanfranconi et al.. “Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial.” Lancet neurology, vol. 22, no. 1, 2023, pp. 35–44. http://access.bl.uk/ark:/81055/vdc_100172069934.0x000032